BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26330272)

  • 21. Investigating the physiological role of S199A and S199D mutants of PHF6 protein in T-cell acute lymphoblastic leukemia.
    Erdoğan G; Özeş ON; Küpesiz A; Yoldaş ŞB
    Turk J Med Sci; 2023; 53(5):1234-1243. PubMed ID: 38812997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct sensitivity of CD8+ CD4- and CD8+ CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model.
    Zhang Y; Hua C; Cheng H; Wang W; Hao S; Xu J; Wang X; Gao Y; Zhu X; Cheng T; Yuan W
    Leuk Res; 2013 Nov; 37(11):1592-601. PubMed ID: 24090996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells.
    Okuhashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2013 Oct; 33(10):4293-8. PubMed ID: 24122995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bortezomib suppresses the growth of leukemia cells with Notch1 overexpression in vivo and in vitro.
    Huang C; Hu X; Wang L; Lü S; Cheng H; Song X; Wang J; Yang J
    Cancer Chemother Pharmacol; 2012 Dec; 70(6):801-9. PubMed ID: 22996635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration.
    Bhavsar PJ; Infante E; Khwaja A; Ridley AJ
    Oncogene; 2013 Jan; 32(2):198-208. PubMed ID: 22349824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of transgenic mice expressing cancer-associated variants of human NOTCH1.
    Berquam-Vrieze KE; Swing DA; Tessarollo L; Dupuy AJ
    Genesis; 2012 Feb; 50(2):112-8. PubMed ID: 21898766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notch in T-ALL: new players in a complex disease.
    Koch U; Radtke F
    Trends Immunol; 2011 Sep; 32(9):434-42. PubMed ID: 21775206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavone inhibited proliferation of T-ALL by promoting c-Cbl-induced ubiquitinylation and degradation of Notch1.
    Zhu W; Zhu Y; Xu H; Wang T; Wang J; Meng M; Liu Y; Yan H; Yang Q; Liu P
    Biochem Biophys Res Commun; 2020 Feb; 522(3):684-689. PubMed ID: 31785807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of Notch signaling by gamma-secretase inhibition can abrogate chemotherapy-induced apoptosis in T-ALL cell lines.
    Liu S; Breit S; Danckwardt S; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2009 Jul; 88(7):613-21. PubMed ID: 19057901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.
    Mavrakis KJ; Wolfe AL; Oricchio E; Palomero T; de Keersmaecker K; McJunkin K; Zuber J; James T; Khan AA; Leslie CS; Parker JS; Paddison PJ; Tam W; Ferrando A; Wendel HG
    Nat Cell Biol; 2010 Apr; 12(4):372-9. PubMed ID: 20190740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hedgehog Stimulation Suppresses Clonogenicity and Activates NOTCH Signalling in T-lymphoblastic Leukaemia Jurkat Cells.
    Okuhashi Y; Itoh M; Tohda S
    Anticancer Res; 2017 Sep; 37(9):5005-5009. PubMed ID: 28870926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.
    de Bock CE; Down M; Baidya K; Sweron B; Boyd AW; Fiers M; Burns GF; Molloy TJ; Lock RB; Soulier J; Taghon T; Van Vlierberghe P; Cools J; Holst J; Thorne RF
    Haematologica; 2019 May; 104(5):e204-e207. PubMed ID: 30514801
    [No Abstract]   [Full Text] [Related]  

  • 34. Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis.
    Oki T; Kitaura J; Watanabe-Okochi N; Nishimura K; Maehara A; Uchida T; Komeno Y; Nakahara F; Harada Y; Sonoki T; Harada H; Kitamura T
    Leukemia; 2012 May; 26(5):1038-45. PubMed ID: 22116551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors.
    Sharma A; Gadkari RA; Ramakanth SV; Padmanabhan K; Madhumathi DS; Devi L; Appaji L; Aster JC; Rangarajan A; Dighe RR
    Sci Rep; 2015 Jun; 5():11012. PubMed ID: 26046801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis.
    Gómez-del Arco P; Kashiwagi M; Jackson AF; Naito T; Zhang J; Liu F; Kee B; Vooijs M; Radtke F; Redondo JM; Georgopoulos K
    Immunity; 2010 Nov; 33(5):685-98. PubMed ID: 21093322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOTCH1-induced T-cell leukemia in transgenic zebrafish.
    Chen J; Jette C; Kanki JP; Aster JC; Look AT; Griffin JD
    Leukemia; 2007 Mar; 21(3):462-71. PubMed ID: 17252014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.
    Bonnet M; Loosveld M; Montpellier B; Navarro JM; Quilichini B; Picard C; Di Cristofaro J; Bagnis C; Fossat C; Hernandez L; Mamessier E; Roulland S; Morgado E; Formisano-Tréziny C; Dik WA; Langerak AW; Prebet T; Vey N; Michel G; Gabert J; Soulier J; Macintyre EA; Asnafi V; Payet-Bornet D; Nadel B
    Blood; 2011 Jun; 117(24):6650-9. PubMed ID: 21527520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of leukemia-induced non-coding activator RNA (LUNAR1) predicts poor outcome in pediatric T-acute lymphoblastic leukemia.
    El-Khazragy N; Abdel Aziz MA; Hesham M; Matbouly S; Mostafa SA; Bakkar A; Abouelnile M; Noufal Y; Mahran NA; Abd Elkhalek MA; Abdelmaksoud MF
    Immunobiology; 2021 Nov; 226(6):152149. PubMed ID: 34735923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOXP3 knockdown inhibits the proliferation and reduces NOTCH1 expression of T cell acute lymphoblastic leukemia cells.
    Yonekura S; Itoh M; Shiratori E; Ohtaka M; Tohda S
    BMC Res Notes; 2018 Aug; 11(1):582. PubMed ID: 30103821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.